HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P L McGeer Selected Research

Biomarkers (Surrogate Marker)

3/2009Tauopathies with parkinsonism: clinical spectrum, neuropathologic basis, biological markers, and treatment options.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P L McGeer Research Topics

Disease

13Alzheimer Disease (Alzheimer's Disease)
01/2013 - 01/2000
5Parkinson Disease (Parkinson's Disease)
01/2013 - 07/2000
5Neurodegenerative Diseases (Neurodegenerative Disease)
01/2013 - 01/2000
5Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
03/2009 - 07/2000
5Inflammation (Inflammations)
02/2006 - 05/2000
5Amyloid Plaque
11/2001 - 12/2000
4Parkinsonian Disorders (Parkinsonism)
03/2009 - 07/2000
4Dementia (Dementias)
03/2009 - 07/2000
4Pick Disease of the Brain (Pick's Disease)
08/2002 - 07/2000
3Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2013 - 07/2000
2Neuroblastoma
01/2013 - 05/2000
2Corticobasal Degeneration
03/2009 - 02/2001
2Down Syndrome (Down's Syndrome)
07/2001 - 07/2000
2Atherosclerotic Plaque (Atheroma)
07/2001 - 03/2001
1Vascular Remodeling
11/2010
1Lewy Body Disease (Lewy Body Dementia)
12/2009
1Synucleinopathies
12/2009
1Type C Niemann-Pick Disease (Niemann Pick Disease, Type C)
03/2009
1Tauopathies
03/2009
1Frontotemporal Dementia (Semantic Dementia)
03/2009
1Prion Diseases (Transmissible Spongiform Encephalopathies)
02/2008
1Autolysis
12/2001
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
09/2001
1Memory Disorders (Memory Loss)
09/2001
1Heart Diseases (Heart Disease)
09/2001
1Stroke (Strokes)
09/2001
1Pathologic Processes
02/2001
1Neoplasms (Cancer)
09/2000
1Infarction (Infarctions)
09/2000
1Seizures (Absence Seizure)
01/2000
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2000
1Reperfusion Injury
01/2000

Drug/Important Bio-Agent (IBA)

7Messenger RNA (mRNA)IBA
12/2001 - 05/2000
5Complement System Proteins (Complement)IBA
09/2001 - 01/2000
4Anti-Inflammatory Agents (Anti-Inflammatories)IBA
01/2013 - 09/2001
3tau Proteins (tau Protein)IBA
03/2009 - 02/2001
3Neprilysin (Neutral Endopeptidase)IBA
11/2001 - 01/2001
3Amyloid beta-PeptidesIBA
11/2001 - 02/2000
3C-Reactive ProteinIBA
11/2001 - 12/2000
2Amyloid (Amyloid Fibrils)IBA
11/2001 - 12/2000
2Proteins (Proteins, Gene)FDA Link
07/2001 - 01/2001
2Casein Kinase IdeltaIBA
07/2000 - 05/2000
1Conditioned Culture MediaIBA
01/2013
1Interferon-gamma (Interferon, gamma)IBA
01/2013
1Laminin (Merosin)IBA
11/2010
1Fibrinogen (Factor I)FDA Link
11/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2010
1Leucine (L-Leucine)FDA Link
12/2009
1alpha-SynucleinIBA
12/2009
1Phosphotransferases (Kinase)IBA
12/2009
1Biomarkers (Surrogate Marker)IBA
03/2009
1Endopeptidase K (Proteinase K)IBA
02/2008
1Prion ProteinsIBA
02/2008
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
02/2006
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
02/2006
1Presenilin-1IBA
11/2001
1Peptides (Polypeptides)IBA
11/2001
1Retinal Pigments (Pigments, Visual)IBA
11/2001
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2001
1CytokinesIBA
09/2001
1Indomethacin (Indometacin)FDA LinkGeneric
09/2001
1Complement C9 (Complement Component 9)IBA
07/2001
1Complement Inactivating AgentsIBA
07/2001
1Carrier Proteins (Binding Protein)IBA
07/2001
1Membrane Cofactor ProteinIBA
07/2001
1Complement Membrane Attack Complex (Membrane Attack Complex)IBA
07/2001
1CD59 AntigensIBA
07/2001
1CD55 Antigens (Decay Accelerating Factor)IBA
07/2001
1Inflammation MediatorsIBA
03/2001
1sarkosylIBA
02/2001
1Protein Isoforms (Isoforms)IBA
02/2001
1Selegiline (E250)FDA LinkGeneric
12/2000
1Monoamine Oxidase (MAO)IBA
12/2000
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
09/2000
1Adenosine Triphosphate (ATP)IBA
09/2000
1Diazoxide (Hyperstat)FDA Link
09/2000
15-hydroxydecanoic acidIBA
09/2000
1LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
09/2000
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
09/2000
1Monoclonal AntibodiesIBA
09/2000
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
07/2000
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
07/2000
1PK 11195 (PK11195)IBA
05/2000
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2000
1LigandsIBA
05/2000
1Glutamic Acid (Glutamate)FDA Link
05/2000
1HLA-DR Antigens (HLA-DR)IBA
05/2000
1Interleukin-1beta (Interleukin 1 beta)IBA
05/2000
1Heparin (Liquaemin)FDA LinkGeneric
01/2000
1Kainic Acid (Kainate)IBA
01/2000
1Bromodeoxyuridine (BrdU)IBA
01/2000

Therapy/Procedure

3Therapeutics
02/2006 - 01/2000